Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
382 studies found for:    HIV AND (coinfection OR tuberculosis OR TB OR malaria OR hepatitis OR HCV OR HBV OR HPV OR human papillomavirus OR Kaposi's Sarcoma OR KS OR EBV OR Epstein-Barr) | Open Studies
Show Display Options
Rank Status Study
21 Unknown  CHANGES IN LIVER STEATOSIS AFTER SWITCHING TO RALTEGRAVIR IN HIV/HCV COINFECTION
Conditions: HCV Coinfection;   HIV Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
22 Unknown  Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients
Conditions: HBV Coinfection;   HIV Infections
Interventions: Drug: raltegravir and tenofovir and lamivudine;   Drug: efavirenz+tenofovir+lamivudine
23 Recruiting HIV-DNA Dynamics in HIV Monoinfected or HIV/HCV Coinfected Patients
Condition: HIV
Intervention: Procedure: Blood sample withdrawal
24 Unknown  Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV
Conditions: HIV;   Hepatitis B
Interventions: Drug: Tenofovir/lamivudine/lopinavir-ritonavir;   Drug: Zidovudine/lamivudine/lopinavir-ritonavir
25 Recruiting The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals
Conditions: Acute Hepatitis C;   HIV
Intervention:
26 Recruiting A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects
Conditions: HIV;   Hepatitis C
Intervention:
27 Unknown  Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir
28 Unknown  A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
Conditions: HIV Infections;   Hepatitis B Virus
Intervention:
29 Recruiting Scaling up TB and HIV Treatment Integration
Conditions: HIV;   Tuberculosis
Intervention: Other: Quality Improvement Model of Care
30 Recruiting A Peer-based Mobile-health Intervention to Increase Access and Adherence to Hepatitis C Treatment and HIV Viral Suppression
Conditions: Hepatitis C;   HIV;   Risk Reduction Behavior
Intervention: Behavioral: Peer Mentor
31 Recruiting Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly
Conditions: HIV;   Tuberculosis
Interventions: Drug: Lopinavir/r will be supplied by NHSO/GPO;   Drug: Rifabutin
32 Recruiting Evaluating the Safety, Tolerance, and Pharmacokinetics of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in Children Infected With HIV and TB
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir
33 Recruiting Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment
Conditions: HIV-1 Infection;   HCV Infection
Interventions: Drug: E/C/F/TAF;   Drug: F/R/TAF;   Drug: LDV/SOF
34 Recruiting Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
Conditions: Hepatitis;   HIV;   Liver Cancer
Intervention:
35 Recruiting Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa
Conditions: Hepatitis B Virus;   HIV;   Antiretroviral Therapy;   Africa;   Liver Fibrosis
Intervention: Other: Standard of care
36 Unknown  Diagnosis of Tuberculosis Infection in HIV Co-infected Children
Conditions: Latent Tuberculosis Infection;   Tuberculosis;   HIV Infections
Intervention:
37 Unknown  Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients
Conditions: Hepacivirus;   HIV Infections
Interventions: Drug: Pentoxifylline;   Drug: Placebo
38 Unknown  HIV-HBV Co-Infection and Liver Disease
Conditions: HIV Infections;   HIV-HBV Co-Infection
Intervention:
39 Recruiting A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination
Conditions: Hepatitis C Infection;   HIV Infection
Interventions: Biological: AdCh3NSmut1;   Biological: MVA-NSmut;   Biological: ChAdV63.HIVconsv;   Biological: MVA.HIVconsv
40 Recruiting Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals
Conditions: Hepatitis C;   HIV
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years